Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Veterinary Microbiology
- Vol. 235, 243-247
Abstract
No abstract availableKeywords
Funding Information
- Grayson-Jockey Club Research Foundation
This publication has 27 references indexed in Scilit:
- Macrolide- and Rifampin-ResistantRhodococcus equion a Horse Breeding Farm, Kentucky, USAEmerging Infectious Diseases, 2013
- Diagnosis, Treatment, Control, and Prevention of Infections Caused by R hodococcus equi in FoalsJournal of Veterinary Internal Medicine, 2011
- R hodococcus equi : Clinical Manifestations, Virulence, and ImmunityJournal of Veterinary Internal Medicine, 2011
- Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equiJournal of the American Veterinary Medical Association, 2010
- Comparison of concentrations of Rhodococcus equi and virulent R. equi in air of stables and paddocks on horse breeding farms in a temperate climateEquine Veterinary Journal, 2006
- Retrospective Comparison of Azithromycin, Clarithromycin, and Erythromycin for the Treatment of Foals with Rhodococcus equi PneumoniaJournal of Veterinary Internal Medicine, 2004
- Rapid Identification ofRhodococcus equiby a PCR Assay Targeting thechoEGeneJournal of Clinical Microbiology, 2003
- Emergence of Rifampin-Resistant Rhodococcus equi with Several Types of Mutations in the rpoB Gene among AIDS Patients in Northern ThailandJournal of Clinical Microbiology, 2003
- Characterization of Mutations in the rpoB Gene Associated with Rifampin Resistance in Rhodococcus equi Isolated from FoalsJournal of Clinical Microbiology, 2001
- In-vitro antimicrobial susceptibility of Rhodococcus equiJournal of Antimicrobial Chemotherapy, 1992